Aura Biosciences Inc
NASDAQ:AURA

Watchlist Manager
Aura Biosciences Inc Logo
Aura Biosciences Inc
NASDAQ:AURA
Watchlist
Price: 9.97 USD -3.48% Market Closed
Market Cap: 494.6m USD
Have any thoughts about
Aura Biosciences Inc?
Write Note

Aura Biosciences Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aura Biosciences Inc
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Aura Biosciences Inc
NASDAQ:AURA
Capital Expenditures
-$709k
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$888m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$974m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-30%
CAGR 5-Years
-45%
CAGR 10-Years
-25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$928.1m
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
-13%

See Also

What is Aura Biosciences Inc's Capital Expenditures?
Capital Expenditures
-709k USD

Based on the financial report for Dec 31, 2023, Aura Biosciences Inc's Capital Expenditures amounts to -709k USD.

What is Aura Biosciences Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
3%

Over the last year, the Capital Expenditures growth was 35%. The average annual Capital Expenditures growth rates for Aura Biosciences Inc have been 3% over the past three years .

Back to Top